VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30067740 | HIV | ENSG00000105835.13 | protein_coding | NAMPT | No | No | 10135 | P43490 |
TVIS30067741 | HIV | ENSG00000105835.13 | protein_coding | NAMPT | No | No | 10135 | P43490 |
TVIS30067742 | HIV | ENSG00000105835.13 | protein_coding | NAMPT | No | No | 10135 | P43490 |
TVIS20014546 | HPV | ENSG00000105835.13 | protein_coding | NAMPT | No | No | 10135 | P43490 |
TVIS20014547 | HPV | ENSG00000105835.13 | protein_coding | NAMPT | No | No | 10135 | P43490 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | NAMPT |
---|---|
DrugBank ID | DB12980 |
Drug Name | CHS-828 |
Target ID | BE0002413 |
UniProt ID | P43490 |
Regulation Type | inhibitor |
PubMed IDs | 21144000 |
Citations | Olesen UH, Petersen JG, Garten A, Kiess W, Yoshino J, Imai S, Christensen MK, Fristrup P, Thougaard AV, Bjorkling F, Jensen PB, Nielsen SJ, Sehested M: Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase. BMC Cancer. 2010 Dec 12;10:677. doi: 10.1186/1471-2407-10-677. |
Groups | Investigational |
Direct Classification | Phenol ethers |
SMILES | ClC1=CC=C(OCCCCCCNC(NC#N)=NC2=CC=NC=C2)C=C1 |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL17289 |